News Archive

On February 27, Ferndale became the 4th Michigan city to begin psychedelic decriminalization, acknowledging the therapeutic applications of psychedelics like psilocybin, ayahuasca and dimethyltryptamine (DMT).

Research suggests that when it comes to reducing anxiety and depression, psychedelic experiences described as mystical, frightening or even destabilizing can lead to a greater reduction in anxiety and depression symptoms.

A recent article from the New Yorker highlights the past and present of A.I. Therapy, spanning all the way back to the 60s and a chat bot names Eliza.

New study explores "spontaneous spiritual awakenings" as scientists seek to understand their similarity to psychedelic experiences

Researchers at Baylor College of Medicine have launched a new program exploring the ethical and legal implications of psychedelic research

An announcement by the Biden administration puts the legality of online ketamine treatment into question.

Australia's Therapeutic Goods Administration approved psilocybin and MDMA for use by people with certain mental health conditions starting July 2023

The first placebo-controlled study looking at DMT as a treatment for depression had encouraging results.

Research shows that bringing the great outdoors, indoors through VR can still elicit the positive effects of being in nature.

It seems 2023 is the year for psychedelic reform. Lawmakers in Connecticut, Massachusetts and Oklahoma file bills to further reasearch.